| Literature DB >> 34141472 |
Takehiro Yamakoshi1,2, Peter Rolfe3,4, Ken-Ichi Yamakoshi5,6,7.
Abstract
BACKGROUND: Although cuff-sphygmomanometry is used worldwide in medical and healthcare fields, it is a fact that the use of an occlusive cuff to obtain blood pressure (BP) is troublesome and inconvenient. There have therefore been on-going efforts to devise methods that do not require the use of a cuff, almost all being based on the measurement of pulse wave velocity or pulse transit time, but so far few significant developments have been made, especially regarding measurement accuracy. We have previously reported a smartphone-based cuffless method using a linear multiple regression calibration model comprising of BP obtained with a cuff-sphygmomanometer as an objective variable and modified normalized pulse volume (mNPV: a measure of vasoconstrictive activity in a finger) and pulse rate (PR) as explanatory variables. This requires a number of subjects to construct a calibration model and thus is largely dependent on the accuracy due to the model. To address these drawbacks, we report here a new cuffless method to surpass considerably the results of our previous study as well as earlier works.Entities:
Keywords: Blood pressure; Cuffless; Haemodynamic principle; Healthcare; Heart disease; Hypertension; Mobile health; Modified normalized pulse volume; Smart; Smartphone
Year: 2021 PMID: 34141472 PMCID: PMC8183454 DOI: 10.7717/peerj.11479
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Summarised subject information and measured values. Summarised values of mean (and S.D.) brachial BP and PR, iPhone-PR and mNPV and estimated BP values, and mean absolute difference MAD values obtained throughout the measurements in each subject. See text for symbols and further explanation.
| Sub. no. | Gender | Age | BMI [kg/m2] | Number of measurements (measurement periods) | Mean ( | Mean ( | Mean absolute difference MAD ( | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAD of | MAD of | MAD of | ||||||||||||||||
| 1 | Female | 19 | 22.7 | 19 (14 days) | 110 (6.3) <113> | 80 (3.9) <81> | 66 (3.0) <65> | 80.7 (7.87) | 80.8 (8.83) <76.8> | 1.05 (0.118) | 5.87 (1.78) <4.16> | 1.41 (0.428) | 107 (6.0) (110 (6.2)) | 84 (4.7) | 71 (4.0) (73 (4.1)) | 3.8 (2.3) (2.4 (1.6) | 3.9 (1.6) | 5.8 (1.6) (7.3 (2.2)) |
| 2 | Female | 21 | 22.6 | 19 (12 days) | 104 (3.7) <111> | 81 (4.1) <85> | 69 (5.0) <72> | 58.7 (5.63) | 58.6 (4.59) <66.2> | 0.88 (0.071) | 3.52 (1.23) <4.04> | 0.87 (0.306) | 103 (5.2) (103 (5.2)) | 79 (4.0) | 67 (3.4) (67 (3.4)) | 2.9 (1.9) (2.9 (1.9)) | 2.0 (1.9) | 3.1 (2.2) (3.1 (2.2)) |
| 3 | Male | 38 | 23.2 | 20 (14 days) | 138 (7.3) <116> | 103 (5.1) <90> | 86 (4.4) <77> | 66.5 (5.64) | 67.2 (6.28) <52> | 1.29 (0.124) | 2.28 (1.01) <1.47> | 1.55 (0.688) | 136 (8.3) (136 (8.3)) | 106 (6.4) | 91 (5.5) (91 (5.5)) | 4.3 (2.0) (4.3 (2.0)) | 3.3 (2.6) | 4.8 (3.0) (4.8 (3.0)) |
| 4 | Female | 39 | 19.4 | 20 (12 days) | 111 (3.5) <112> | 85 (3.4) <86.7> | 72 (4.4) <74> | 71.3 (6.17) | 72.1 (4.64) <72.6> | 0.99 (0.066) | 3.78 (1.18) <3.80> | 0.99 (0.311) | 112 (5.5) (112 (5.5)) | 87 (4.3) | 74 (3.6) (74 (3.6)) | 4.2 (2.9) (4.2 (2.9)) | 3.9 (2.0) | 4.1 (3.0) (4.1 (3.0)) |
| 5 | Female | 45 | 20 | 20 (11 days) | 103 (5.9) <95> | 71 (4.4) <65.7> | 56 (4.1) <51> | 69.1 (5.73) | 68.3 (5.36) <71.1> | 0.96 (0.078) | 2.45 (0.656) <3.76> | 0.65 (0.174) | 104 (5.7) (104 (5.8)) | 72 (4.0) | 56 (3.1) (56 (3.1)) | 2.8 (1.8) (2.8 (1.9)) | 1.8 (1.3) | 1.9 (1.6) (1.9 (1.6)) |
| 6 | Male | 46 | 21.9 | 18 (19 days) | 124 (7.6) <125> | 92 (5.1) <90> | 76 (4.8) <72> | 66.1 (4.67) | 68.3 (2.90) | 0.94 (0.041) | 4.10 (1.02) <4.42> | 0.93 (0.233) | 120 (7.1) (120 (7.1)) | 86 (5.1) | 69 (4.1) (69 (4.3)) | 3.7 (2.0) (3.6 (2.0) | 5.6 (2.8) | 7.1 (3.1) (7.1 (3.1)) |
| 7 | Female | 53 | 23.1 | 20 (12 days) | 105 (6.4) <110> | 78 (5.0) <82> | 64 (5.3) <68> | 55.9 (3.57) | 56.3 (3.33) <49> | 1.15 (0.074) | 6.22 (1.76) <3.40> | 1.82 (0.515) | 105 (6.9) (105 (6.9) | 78 (5.1) | 65 (4.3) (65 (4.3)) | 3.6 (2.1) (3.6 (2.1)) | 2.4 (1.5) | 3.1 (2.3) (3.1 (2.3)) |
| 8HY | Male | 67 | 24.9 | 19 (10 days) | 139 (7.6) <142> | 98 (4.7) <99.3> | 77 (4.4) <78> | 70.4 (3.57) | 70.1 (3.64) <65.7> | 1.07 (0.057) | 7.52 (2.00) <5.90> | 1.27 ((0.339) | 140 (10.1) (140 (10.1)) | 98 (7.1) | 77 (5.5) (77 (5.5-)) | 4.7 (2.5) (4.7 (2.5)) | 3.2 (2.1) | 3.7 (2.4) (3.7 (2.4)) |
| 9 | Male | 67 | 27.3 | 19 (5 days) | 125 (10.2) <118> | 91 (6.2) <88> | 74 (5.0) <73> | 64.7 (5.10) | 63.8 (3.65) <62.3> | 1.02 (0.060) | 8.48 (2.38) <9.16> | 0.93 (0.259) | 126 (10.2) (126 (10.2)) | 94 (7.6) | 78 (6.3) (78 (6.3)) | 2.8 (1.7) (2.8 (1.7)) | 3.9 (2.4) | 5.3 (3.3) (5.3 (3.3)) |
| 10 | Female | 71 | 20.6 | 17 (12 days) | 121 (6.2) <117> | 90 (4.6) <87> | 75 (4.5) <72> | 70.2 (4.25) | 70.4 (4.77) <72.0> | 0.98 (0.068) | 7.51 (2.25) <5.45> | 1.37 (0.413) | 121 (7.3) (121 (7.3)) | 90 (5.4) | 75 (4.5) (75 (4.5)) | 3.5 (2.7) (3.5 (2.8)) | 3.6 (2.1) | 3.9 (2.4) (3.9 (2.4)) |
| 11HY | Male | 72 | 24.9 | 61 (119 days) | 138 (11.9) <134> <2nd: 128> <3rd: 128> | 99 (8.8) <95.3> <2nd: 93.3> <3rd:90> | 80 (8.0) <76> <2nd: 76> <3rd: 71> | 64.1 (5.19) | 64.1 (5.08) <68> <2nd: 72> <3rd: 67> | 0.97 (0.084) 2nd 0.84 (0.068) 3rd 0.96 (0.071) | 2.89 (1.35) <2.79> <2nd: 8.13> <3rd: 3.80> | 0.69 (0.239) 2nd 0.50 (0.260) 3rd 0.75 (0.284) | 138 (11.9) (138 (11.9)) | 98 (8.8) | 78 (7.3) (78 (7.3)) | 2.8 (2.0) (2.8 (2.0)) | 3.7 (2.7) | 5.0 (3.4) (5.0 (3.4) |
| 12HY | Female | 72 | 19.7 | 17 (6 days) | 120 (9.3) <115> | 86 (6.9) <84.3> | 69 (6.4) <69> | 68.1 (2.89) | 69.7 (4.12) <77.8> | 0.90 (0.055) | 5.17 (1.91) <7.14> | 0.73 (0.267) | 118 (10.7) (117 (10.6)) | 86 (7.8) | 71 (6.4) (70 (6.4)) | 4.1 (2.9) (4.1 (2.9)) | 2.3 (2.1) | 2.8 (2.7) (2.7 (2.7)) |
| 13HY | Male | 72 | 26.7 | 30 (14 days) | 136 (13.4) <139> | 97 (9.0) <98> | 78 (7.5) <78> | 65.1 (7.84) | 65.0 (7.17) <65.9> | 0.99 (0.11) | 4.79 (1.76) <8.05> | 0.60 (0.219) | 136 (12.1) (136 (12.3)) | 99 (9.5) | 81 (8.4) (80 (8.4)) | 3.3 (2.5) 3.1 (2.4) | 3.7 (2.3) | 5.1 (3.0) 5.1 (3.0) |
| Total | 3.5 (2.3) (3.3 (2.3)) | 3.4 (2.4) | 4.4 (3.1) (4.5 (3.2) | |||||||||||||||
Notes:
(a) superscript HY means hypertension with grade one, taking antihypertensive agents everyday.
(b) "Number of measurements" indicate the number excluded from the initial setting procedure in all subjects except that in the subject No. 11, in which the number is excluded from the initial setting and two times resetting procedures.
Figure 1Illustrative drawings of measurement scenes.
Illustrative drawings of measurement scenes by a smartphone (iPhone) (A) and a conventional cuff-based sphygmomanometer (B).
Figure 2Accuracy of estimated values obtained with the proposed method.
Accuracy of estimated values obtained with the proposed method. Scatterplots of SBP (A), MAP (B), DBP(C) and total BP (including all of SBP, MBP and DBP) values (D) estimated using a smartphone against the values determined with a brachial cuff sphygmomanometer (n = 299 for SBP, MBP and DBP and n = 897 for total). Lines of identity (solid orange lines), regression lines (solid black lines) and regression formula together with the coefficient of determination R2 and the correlation coefficient r values are shown in each scatterplot. Corresponding Bland–Altman plots of SBP (E), MAP (F), DBP (G) and total BP values (H). Solid and dashed lines represent the fixed bias and the limits of agreement (bias ± 1.96 S.D.). (S.D.: standard deviation), respectively. Average = (brachial + estimate)/2, Difference = brachial − estimate. Pearson’s r values are also presented in each graph.
Figure 3An example of a trend chart.
An example of a trend chart of 61 data sets of SBPc/MBPc/DBPc and corresponding SBPe/MBPe/DBPe values obtained in one subject (No. 11) with the prolonged measurement period for about 4 months. See text for further explanation.